As of May 02
| -0.0383 / -7.18%|
The 3 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 2.00, with a high estimate of 2.95 and a low estimate of 0.75. The median estimate represents a +303.80% increase from the last price of 0.50.
The current consensus among 3 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.